Quintrio
Home

Stock overview

Cheetah Mobile Inc. American Depositary Shares, each representing fifty (50) Class A Ordinary Shares

CMCM

Cheetah Mobile Inc along with its subsidiaries provides comprehensive products and services on PCs and mobile devices. It generates revenue from utility-related business, including advertising services and premium membership services. It also provides multi-cloud management platform and overseas advertising agency service. The company operates in two segments: Internet business, and AI and others. The companies products and services includes Robotic Products, Global to B Services etc. The firm's majority of the revenue is derived from the internet business segment that provides mobile advertising services to advertising customers, as well as selling advertisements and referring user traffic on its mobile and PC platforms. Geographically, it derives the majority of its revenue from the PRC.

Last trade $2.00
Day change -$0.03 (-1.48%)
Day range $1.99 – $2.16
Volume 7,272
Market cap $63M

Open XNYS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

No ratio data was found for CMCM.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

Income statement for CMCM, quarterly periods
Line itemQ4 FY2014 Dec 31, 2014
Revenue—
Cost of revenue$0
Gross profit—
Selling, general and administrative—
Research and development—
Total operating expenses—
Operating income—
Interest expense—
Income before taxes—
Income taxes—
Net income—
Net income attributable to common shareholders—
EBITDA$0
Basic earnings per share—
Diluted earnings per share—

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
Benzinga

Top 4 Tech Stocks You May Want To Dump In April

As of April 16, 2024, four stocks in the information technology sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70, according to Benzinga Pro. Here’s the latest list of major overbought players in this sector. Red Cat Holdings, Inc. ...

Benzinga

Top 4 Tech Stocks That May Implode This Month

As of March 4, 2024, four stocks in the information technology sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70, according to Benzinga Pro. Here’s the latest list of major overbought players in this sector. Box, Inc. (NYSE: BOX) Box will replace Forrester Research in the S&P SmallCap ...

Benzinga

Why Allena Pharmaceuticals Tumbled Over 30%; Here Are 85 Biggest Movers From Yesterday

Gainers Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) shares jumped 91.3% to close at $28.50 on Tuesday amid post-IPO volatility. IVERIC bio, Inc. (NASDAQ: ISEE) rose 66.3% to close at $15.70 on Tuesday after the company announced positive data from the second Phase 3 trial of Zimura (avacincaptad pegol) for geographic atrophy (GA). HyreCar Inc. (NASDAQ: HYRE) climbed 58.1% to close at $1.27 on Tuesday after the company announced it has received a $100 million revolving line of credit from a premier global investment bank and Medalist Partners. Spero Therapeutics, Inc. (NASDAQ: SPRO) gained 55.5% to close at $1.13. Spero Therapeutics received minutes from a recent Type A meeting with the FDA, discussing steps required to resubmit the marketing application for tebipenem HBr for complicated urinary tract infection (cUTI). ChannelAdvisor Corporation (NYSE: ECOM) shares jumped 55% to settle at $22.79 after the company announced it will be acquired by CommerceHub for $23.10 per share. Akumin Inc. (NASDAQ: AKU) climbed 37% to close at $1.63. Akumin recently received notification letter from the Nasdaq confirming that company had regained compliance with minimum bid price requirement. Apexigen, Inc. (NASDAQ: APGN) rose 34.4% to close at $7.03. First Wave BioPharma, Inc. (NASDAQ: FWBI) shares gained 32.7% to close at $4.22 after gaining 7% on Friday. Galera Therapeutics, Inc. (NASDAQ: GRTX) jumped 29.5% to settle at $1.67. Galera Therapeutics, last month, posted a Q2 loss of $0.54 per share. HilleVax, Inc. (NASDAQ: HLVX) rose 24.8% to close at $17.05. HilleVax recently said Safety Data Monitoring Committee has recommended continuation of NEST-IN1 Phase 2b clinical trial. T Stamp Inc. (NASDAQ: IDAI) gained 24.6% to close at $1.72. Sunrise New Energy Co., Ltd. (NASDAQ: EPOW) jumped 24.6% to close at $3.49. Avaya Holdings Corp. (NASDAQ: AVYA) gained 24% to close at $2.12. Avalo Therapeutics, Inc. (NASDAQ: AVTX) rose 22.3% to settle at $5.87. Avalo advanced BTLA agonist fusion protein (AVTX-008) to IND-enabling stage. BioVie Inc. (NASDAQ: BIVI) rose 21.6% to close at $3.44. Ainos, Inc. (NASDAQ: AIMD) gained 21.1% to close at $2.24. Ainos recently submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration for conducting a Phase 2 trial of its drug candidate VELDONA, for treatment of mild symptoms related to COVID-19. Neonode Inc. (NASDAQ: NEON) jumped 18.7% to settle at $4.26. Neonode, last month, posted a Q2 loss of $0.11 per share. Grove Collaborative Holdings, Inc. (NYSE: GROV) gained 18.4% to close at $5.80. a.k.a. Brands Holding Corp. (NYSE: AKA) surged 17.4% to settle at $2.36. SelectQuote, Inc. (NYSE: SLQT) climbed 16.8% to settle at $1.11. SelectQuote recently said Q4 sales results were lower year-over-year and issued FY23 sales guidance below analyst estimates. ADT Inc. (NYSE: ADT) rose 16.4% to close at $8.39 after the company announced it has secured investments totaling $1.5 billion from State Farm and Google. Dermata Therapeutics, Inc. (NASDAQ: DRMA) gained 15.3% to close at $0.70. Dermata Therapeutics recently posted a Q2 loss of $0.24 per share Regulus Therapeutics Inc. (NASDAQ: RGLS) gained 14.1% to close at $1.62. Regulus Therapeutics, last ...

Benzinga

Why HyreCar Is Trading Higher By 60%, Here Are 63 Stocks Moving In Tuesday's Mid-Day Session

Gainers HyreCar Inc. (NASDAQ: HYRE) jumped 60% to $1.2680 after the company announced it has received a $100 million revolving line of credit from a premier global investment bank and Medalist Partners. ChannelAdvisor Corporation (NYSE: ECOM) shares climbed 54.9% to $22.77 after the company announced it will be acquired by CommerceHub for $23.10 per share IVERIC bio, Inc. (NASDAQ: ISEE) gained 41.4% to $13.35 after the company announced positive data from the second Phase 3 trial of Zimura (avacincaptad pegol) for geographic atrophy (GA). Nutex Health, Inc. (NASDAQ: NUTX) rose 39% to $3.33. Nutex Health recently reported Q2 earnings results. Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) rose 37.4% to $20.47 amid post-IPO volatility. First Wave BioPharma, Inc. (NASDAQ: FWBI) shares climbed 34.1% to $4.2650 after gaining 7% on Friday. Spero Therapeutics, Inc. (NASDAQ: SPRO) surged 30% to $0.9472. Spero Therapeutics received minutes from a recent Type A meeting with the FDA, discussing steps required to resubmit the marketing application for tebipenem HBr for complicated urinary tract infection (cUTI). Rubius Therapeutics, Inc. (NASDAQ: RUBY) jumped 20% to $1.11 after climbing over 23% on Friday. Kaspien Holdings Inc. (NASDAQ: KSPN) rose 18.7% to $2.92. CytomX Therapeutics, Inc. (NASDAQ: CTMX) gained 18.5% to $1.73. CytomX Therapeutics, last month, posted a Q2 loss of $0.37 per share. SelectQuote, Inc. (NYSE: SLQT) jumped 17.3% to $1.1150. SelectQuote recently said Q4 sales results were lower year-over-year and issued FY23 sales guidance below analyst estimates. Pear Therapeutics, Inc. (NASDAQ: PEAR) rose 16% to $2.47. Pear Therapeutics, last month, posted Q2 EPS of $0.04. LifeStance Health Group, Inc. (NASDAQ: LFST) gained 16% to $7.93. Apexigen, Inc. (NASDAQ: APGN) gained 15.9% to $6.06. Regulus Therapeutics Inc. (NASDAQ: RGLS) jumped 15.4% to $1.6383. Regulus Therapeutics, last month, posted a Q2 loss of $0.50 per share. American Virtual Cloud Technologies, Inc. (NASDAQ: AVCT) gained 15% to $0.2428. American Virtual Cloud Technologies recently announced an equity distribution agreement to offer and sell up to $14.7 million shares of common stock. Akumin Inc. (NASDAQ: AKU) gained 13.4% to $1.35. Akumin recently ...

Benzinga

Bed Bath & Beyond, Eiger BioPharmaceuticals And Some Other Big Stocks Moving Lower On Tuesday

ProKidney Corp. (NASDAQ: PROK) shares tumbled 31.3% to $7.01. ProKidney recently named Glenn Schulman, PharmD, MPH, as Senior Vice President of Investor Relations. Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) shares fell 25.8% to $6.34 after the company provided an update on the status of its planned request for EUA of peginterferon lambda, saying "the agency has indicated that it is not yet able to determine whether the criteria for the submission of an application and issuance of an EUA are likely to be met." Digital World Acquisition Corp (NASDAQ: DWAC) shares fell 19.2% to $20.20. ...

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

Ex-dividendAmount / sharePay dateType
Jun 22, 2020$7.20Jul 9, 2020special
Sep 12, 2019$2.50Sep 30, 2019special

Stock splits

Historical share-structure events and their execution dates.

Updated daily
Execution dateSplit ratioEvent type
Sep 2, 20221-for-5reverse split